Position in SPRB
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$13,500,000
+$7,277,083 QoQ
Shares Held
250,000
+66037.6% QoQ
Ownership
8.70%
of shares outstanding
% of Portfolio
1.22%
of 13F equity value
Holder Rank
#1
of 63 holders
Holding Since
Mar 2023
5 quarters on record
Voting authority
Sole 76%
Shared 24%
None 0%
Common Shares in SPRB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AIGH Capital Management LLC holds $149,698,985 across 14 Biotechnology names. SPRB ranks #5 (9.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | FENC |
Fennec Pharmaceuticals Inc.
|
2,486,038 | $26,724,908 | |
| 2 | KYTX |
Kyverna Therapeutics, Inc.
|
2,795,797 | $24,910,550 | |
| 3 | ABEO |
Abeona Therapeutics Inc.
|
2,987,000 | $18,459,660 | |
| 4 | ARDX |
Ardelyx, Inc.
|
3,200,000 | $16,319,999 | |
| 5 | SPRB |
Spruce Biosciences, Inc.
This page
|
250,000 | $13,500,000 | |
| 6 | VNDA |
Vanda Pharmaceuticals Inc.
|
2,044,169 | $12,510,313 | |
| 7 | PTHS |
Pelthos Therapeutics Inc.
|
329,098 | $9,300,309 | |
| 8 | PYPD |
PolyPid Ltd.
|
1,504,741 | $7,644,084 |
All Filings in SPRB
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,500,000 | 250,000 | Shares | Other | 2026-08-07 | |
| 2023-12-31 | $6,222,917 | 2,123,863 | Shares | Other | 2024-02-12 | |
| 2023-09-30 | $2,736,859 | 1,211,000 | Shares | Other | 2023-11-13 | |
| 2023-06-30 | $2,388,649 | 1,111,000 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $2,439,839 | 1,104,000 | Shares | Other | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||